Sarepta Therapeutics | SRPT - PE Price to Earnings

Stock Price
18.84
Daily Change
0.72 3.97%
Monthly
-17.37%
Yearly
-82.38%
Q1 Forecast
18.29

Sarepta Therapeutics reported $27.27 in PE Price to Earnings for its fiscal quarter ending in June of 2025.





Pe Change Date
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
Agios Pharmaceuticals USD 3.56 0.68 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen USD 25.31 15.82 Dec/2025
Biogen USD 14.02 4.63 Dec/2025
BioMarin Pharmaceutical USD 19.24 0.21 Dec/2025
Capricor Therapeutics 2.76K 2.76K Dec/2022
Daiichi Sankyo JPY 20.73 1.74 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Gilead Sciences USD 15.63 0.08 Dec/2025
Incyte USD 14.84 2.79 Dec/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Moderna USD 27.22 14.51 Jun/2023
Neurocrine Biosciences USD 835.47 802.2 Dec/2025
Novavax 2.28 346.03 Mar/2025
Pfizer USD 14.48 5.18 Dec/2025
PTC Therapeutics USD 9.98 3.25 Dec/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Roche Holding CHF 16.09 3.51 Dec/2025
Sanofi EUR 11.99 1.58 Dec/2025
Sarepta Therapeutics USD 27.27 0 Jun/2025
Tectonic Therapeutic USD 4.01 0.63 Mar/2024
Vertex Pharmaceuticals USD 26.15 2.22 Dec/2025